Your browser doesn't support javascript.
loading
Loureirin B alleviates cardiac fibrosis by suppressing Pin1/TGF-ß1 signaling.
Cheng, Mian; Yang, Zhen; Li, Ruichao; Wu, Gang; Zhang, Cuntai.
Affiliation
  • Cheng M; Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Yang Z; Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Li R; Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Wu G; Department of Cardiology, Renmin Hospital of Wuhan University, China Cardiovascular Research Institute of Wuhan University, Wuhan, China. Electronic address: wugangmd@163.com.
  • Zhang C; Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: zhangcuntaiwh@163.com.
Eur J Pharmacol ; 918: 174791, 2022 Mar 05.
Article in En | MEDLINE | ID: mdl-35093323

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Resins, Plant / Transforming Growth Factor beta1 / NIMA-Interacting Peptidylprolyl Isomerase / Myocardium Type of study: Prognostic_studies Limits: Animals Language: En Journal: Eur J Pharmacol Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Resins, Plant / Transforming Growth Factor beta1 / NIMA-Interacting Peptidylprolyl Isomerase / Myocardium Type of study: Prognostic_studies Limits: Animals Language: En Journal: Eur J Pharmacol Year: 2022 Document type: Article Affiliation country: Country of publication: